Episode: 77 - Derek Lowe on AI and the US Biotech Ecosystem

from The Chain: Protein Engineering Podcast · host Cambridge Healthtech Institute

September 16, 2025 | With the rise of AI and automation, what is the core human skill in drug discovery that is and will be valuable in the future? Derek Lowe, director of Chemical Biology Therapeutics at Novartis and author of the In the Pipeline blog, discusses the impact of AI—and non-AI technologies—on the business of drug making. With host Christopher Bahl, cofounder and CEO of AI Proteins, their conversation covers the value of a PhD in the tech world today, the long-term impacts of knowledge creation in US leadership positions, how the industry can navigate a biotech winter, and more. Links from this episode: AI Proteins Novartis In the Pipeline

Episode metadata supplied by the publisher feed · Published Sep 16, 2025

Embed this episode

Attribution link and audio player

Ready to play

Episode: 77 - Derek Lowe on AI and the US Biotech Ecosystem

0:00 42:25

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Chain: Protein Engineering Podcast?

This episode is 42 minutes long.

When was this The Chain: Protein Engineering Podcast episode published?

This episode was published on September 16, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this The Chain: Protein Engineering Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!